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Abstract
Here we investigate how ß-adrenergic stimulation of the heart alters regulation of ryanodine receptors (RyRs) by
intracellular Ca2+ and Mg2+ and the role of these changes in SR Ca2+ release. RyRs were isolated from rat hearts, perfused in
a Langendorff apparatus for 5 min and subject to 1 min perfusion with 1 mM isoproterenol or without (control) and snap
frozen in liquid N2 to capture their phosphorylation state. Western Blots show that RyR2 phosphorylation was increased by
isoproterenol, confirming that RyR2 were subject to normal ß-adrenergic signaling. Under basal conditions, S2808 and
S2814 had phosphorylation levels of 69% and 15%, respectively. These levels were increased to 83% and 60%, respectively,
after 60 s of ß-adrenergic stimulation consistent with other reports that ß-adrenergic stimulation of the heart can
phosphorylate RyRs at specific residues including S2808 and S2814 causing an increase in RyR activity. At cytoplasmic [Ca2+]
,1 mM, ß-adrenergic stimulation increased luminal Ca2+ activation of single RyR channels, decreased luminal Mg2+
inhibition and decreased inhibition of RyRs by mM cytoplasmic Mg2+. At cytoplasmic [Ca2+] .1 mM, ß-adrenergic
stimulation only decreased cytoplasmic Mg2+ and Ca2+ inhibition of RyRs. The Ka and maximum levels of cytoplasmic Ca
2+
activation site were not affected by ß-adrenergic stimulation. Our RyR2 gating model was fitted to the single channel data.
It predicted that in diastole, ß-adrenergic stimulation is mediated by 1) increasing the activating potency of Ca2+ binding to
the luminal Ca2+ site and decreasing its affinity for luminal Mg2+ and 2) decreasing affinity of the low-affinity Ca2+/Mg2+
cytoplasmic inhibition site. However in systole, ß-adrenergic stimulation is mediated mainly by the latter.
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Introduction
Exercise and stress induce the sympathetic ‘‘fight or flight’’
response that increases heart rate and contractility. During this
response, increased catecholamine concentrations stimulate car-
diac b-adrenergic receptors, resulting in adenylyl cyclase activa-
tion, increased cyclic AMP and increased activity of cyclic AMP-
dependent protein kinase A (PKA). Increased intracellular [Ca2+]
causes Ca2+/calmodulin dependent protein kinase II (CaMKII)
autophosphorylation so that it remains active at low [Ca2+] [1,2].
PKA and CaMKII phosphorylation increase Ca2+-transport
activity that underlies contraction and pacemaking in cardiac
cells [1,3–6].
Systolic contraction follows activation of sarcolemmal voltage-
gated L-type Ca2+ channels during an action potential resulting in
Ca2+-influx, which activates cardiac ryanodine receptor (RyR2)
calcium release channels on the sarcoplasmic reticulum (SR, major
intracellular Ca2+ store). The subsequent rise in cytoplasmic
[Ca2+] causes contraction. Diastolic relaxation occurs with
cessation of Ca2+ release and Ca2+ sequestration by the SR Ca2+
uptake transporter (sarcoplasmic/endoplasmic reticulum Ca2+-
ATPase) [7].
Three phosphorylation sites have been confirmed by 32P
incorporation assays and known to be phosphorylated in vivo;
namely S2808/S2809, S2814/S2815 (depending on the species)
and S2030 [2,8,9]. Mass spectroscopy of the RyR2 phosphoryla-
tion domain (aa2699–2904) has revealed additional, in vitro
phosphorylation sites on RyR2 [10,11] at S2810, S2811, S2797
and T2876. Present understanding of the contribution of RyR2 to
ß
RyR2 is regulated by phosphorylation within the cell. Most
investigations show increased RyR2 activity in lipid bilayers with
in vitro phosphorylation at these sites by exogenous PKA and
CaMKII [8,12] (although [13] reports that CaMKII inhibits
RyR2), increasing RyR2 sensitivity to luminal Ca2+ [14] and
decreasing cytoplasmic Mg2+ inhibition [12]. However, it is not
clear if exogenous enzymes can replicate the mechanisms of RyR2
phosphorylation at rest or during ß adrenergic stimulation.
Therefore, just how ß-adrenergic signaling alters regulation of
RyR2 by luminal and cytoplasmic Ca2+ and Mg2+ is unknown. In
this study, we perfused isolated rat hearts with the ß-adrenergic
agonist, isoproterenol, then incorporated RyR2 from these hearts
into artificial lipid bilayers whilst preserving their phosphorylation
state. The response of RyRs to luminal and cytoplasmic Ca2+ and
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-adrenergic stimulation is limited by a lack of knowledge of how
Mg2+ indicated significant and novel changes in RyR2 function
associated with increased RyR2 phosphorylation at S2808 and
S2814 induced by ß
to measure RyR2 regulation under diastolic [Ca2+] and [Mg2+]
(their activity is too low), we used a RyR2 gating model to predict
the effects of ß
cells under diastolic conditions.
Methods
Perfusion of Isolated Rat Hearts
Healthy male adult rats (Sprague-Dawley) were heparinized
(2000 U, injection BP), and anesthetized with Isoflurane. Hearts
were rapidly removed and immediately perfused via the
Langendorff method (see Methods S1 in File S1). Hearts were
perfused with Krebs Henseleit buffer for 5 min after which they
were either perfused in buffer with or without 1 mM isoproterenol
for 1 min, while monitoring heart performance. Following
perfusion, hearts were rapidly frozen in liquid nitrogen to preserve
phosphorylation and stored at 280uC.
SR Vesicle Preparation
Liquid nitrogen-frozen hearts were homogenized in buffer
containing 10 mM imidazole, 0.5 mM DTT, 3 mM sodium azide,
0.29 M sucrose, 1 mg/ml leupeptin, 1 mg/ml pepstatin A, 1 mM
benzamidine, 0.5 mM PMSF, 20 mM NaF, pH 6.9 (homogeni-
zation buffer). Homogenization was carried in 3615 s bursts with
a rotor-stator homogenizer (HD Scientific) followed by 10 manual
strokes of a loose glass/glass Dounce homogenizer. The homog-
enate was then centrifuged at 7000 rpm for 20 min in Beckman
Optima L-100XP Ultracentrifuge. The resulting supernatant was
centrifuged at 50000 rpm for 30 min. The pellet from this step
was re-homogenized with a tight manual glass/glass Dounce
homogenizer in homogenization buffer also containing 0.65 M
KCl (storage buffer, pH 6.7), incubated for 30 min and then
centrifuged at 7000 rpm for 15 min. The supernatant was
centrifuged at 50000 rpm for 1 h, and the resulting pellet was
resuspended in storage buffer, snap frozen in liquid nitrogen and
stored at 280uC. The NaF present in our buffers was to prevent
ongoing activity of phosphatases (PP1 and PP2A) during SR
vesicle preparation. The whole procedure was carried out at 4uC.
Single Channel Recordings
Lipid bilayers were formed form a mixture of phosphatidyleth-
anolamine and phosphatidylcholine (8:2 wt/wt) in 50 mg/ml n-
decane. Lipid bilayers were formed across a delrin hole
(approximately 100 mm diameter), separating two experimental
compartments, cis (cytoplasmic) and trans (luminal). For vesicle
fusions the cis solution contained (mM): 250 Cs+ (230 CsCH3O3S,
20 CsCl, both from Sigma Aldrich), 1–5 CaCl2 (BDH Chemicals),
and 500 Mannitol (Ajax Chemicals); while trans solution contained
(mM): 50 Cs+ (30 CsCH3O3S, 20 CsCl), 0.1 CaCl2 and 10 TES.
For channel recordings, [Cs+] in trans solution was raised to
250 mM by adding an appropriate volume of 4 M CsCH3O3S.
During experiments the composition of the cis solution was altered
by local perfusion, which provided solution exchange within ,1 s
[15], and the composition of the trans solutions was altered by
addition of aliquots of stock solutions. All experiments were
performed at room temperature (21–26uC).
All solutions were made with MilliQ water and were pH
buffered with 10 mM TES (N-tris [hydroxymethyl] methyl-2-
aminoethanesulfonic acid; ICN Biomedicals) and adjusted to
pH 7.4 by CsOH (ICN Biomedicals), using a TPS digital pH
meter. Free [Ca2+] #3 mM was buffered using 4.5 mM BAPTA
(1,2-bis (2-aminophenoxy) ethane- N, N, N’, N’- tetraacetic acid;
Invitrogen) and additional 1 mM dibromo BAPTA was used for
10 mM free Ca2+. Sodium citrate was used to adjust free [Ca2+]
between 10–50 mM. A Ca2+ electrode (Radiometer) was used to
determine free [Ca2+] in the experimental solutions and the purity
of Ca2+ buffers and Ca2+ stock solutions using titrations against
a 100 mM CaCl2 standard (Fluka).
All recording solutions contained ATP (2 mM, sodium salt from
Sigma Chemicals), which buffers Mg2+. The Ca2+ electrode was
used to determine the purity of the ATP stock solutions by
titrations against the 100 mM CaCl2 standard. Free [Mg
2+] was
estimated using published association constants [16] and the
program ‘‘Bound and Determined’’ [17]. The free [Mg2+] was
confirmed using the fluorescent magnesium indicator, Mag-fura-2
(tetra potassium salt from Molecular Probes). The ratio of
fluorescence intensities at 340 and 380 nm were calibrated in
the experimental solutions (250 mM Cs+ solutions, see above) also
containing 5 mM Mag-fura-2, 4.5 mM BAPTA, (free [Ca2+]
,1 mM) and MgCl2 from aliquots of a calibrated stock.
SDS PAGE and Western Blotting
Standard techniques were used for SDS PAGE and Western
Blotting (see Methods S1 in File S1 details). Phospho-antibodies
were obtained from Badrilla (UK). To establish loading controls,
each membrane probed with phospho-antibodies was re-probed
with anti-RyR2 (C3–33 from Abcam) after quenching of HRP
activity with sodium azide (3% w/v for 3 h at room temperature;
see Figure S1 in File S2) [18]. The ratio of binding of phospho-
and RyR2- antibodies was used to measure the degree of RyR2
phosphorylation.
In-vitro Phosphorylation and Dephosphorylation Assays
Phosphorylation of RyR2 was determined by probing heart SR
isolates using phospho-specific antibodies against S2808 and
S2814 (pS2808 and pS2814, respectively). We also used an
antibody against dephosphorylated S2808 (DepS2808) as a cross
check for pS2808. The average degree of S2808 phosphorylation
was quantified as both pS2808 immunostaining relative to
maximum PKA phosphorylation and also DepS2808 staining (1-
DepS2808 staining) relative to minimal phosphorylation in PP1
incubated samples. Similarly, S2814 phosphorylation was ex-
pressed as pS2814 immunostaining relative to maximal phosphor-
ylation levels achieved using calcium calmodulin (CaCaM) to
activate endogenous CaMKII. Maximal and minimal phosphor-
ylation levels were determined from the time courses of
phosphorylation during incubations with PP1, PKA and CaCaM
(see Methods S1 in File S1 and Figures S2, S3, and S4 in File S2,
respectively).
We tested that our anti-pS2808 and anti-pS2814 antibodies had
the same specificity in detecting PKA and CaMKII phosphory-
lation of RyR2 as seen in a previous study [19]. We subjected PP1-
dephosphorylated RyR2 to successive incubations of PKA and
CamKII (or in reverse order, see Methods S1 in File S1) and
followed the time course of staining by both antibodies (Figures S3
and S4 in File S2). We found that 10 min incubations with PP1
caused maximal decrease in RyR2 phosphorylation at S2808
(Figures S2, S3, and S4 in File S2). Subsequent PKA incubation
for 20 min produced near maximal S2808 phosphorylation and
also increased antibody staining by S2814 to 20% of maximal
levels attainable with CaMKII phosphorylation. Alternatively,
CamKII incubation of PP1 dephosphorylated RyRs for 10 min
produced maximal S2814 phosphorylation and also increased
antibody staining by S2808 to 50% of maximal levels attainable
with PKA phosphorylation. Thus, antibodies for S2808 respond to
ß-Adrenergic Stimulation of RyR2
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-adrenergic stimulation. Since it is not feasible
-adrenergic stimulation on RyR2 activity within
CamKII mediated phosphorylation and those for S2814 respond
to PKA phosphorylation as reported previously [19].
Since fusion of vesicles with lipid bilayers was performed in the
absence of phosphatase inhibitors, we determined if RyRs could
maintain their phosphorylation levels at S2808 during vesicle
fusion by incubating vesicles in the buffers used for vesicle fusion
and channel recording. We found no significant decrease in
phosphorylation of S2808 during incubation with vesicle fusion
buffers over a period of 30 min (Figure S5 in File S2). Since single
channel experiments were performed with ATP, we determined
whether ATP could phosphorylate S2814 via endogenous
CaMKII/calmodulin [20] SR vesicles from control hearts in-
cubated for 10 min in buffers containing 2 mM ATP, without
exogenous CaMKII or calmodulin, did not exhibit increased
S2814 phosphorylation (Figure S6 in File S2).
Statistics
All data are shown as mean 6 standard error of the mean
(SEM). Significance was calculated by Student’s t test. p,0.05 was
considered significant.
Ethics Statement
All experimental procedures were approved by the University of
Newcastle Animal Care and Ethics Committee (A-2009-153).
Results
Confirmation of ß-adrenergic Stimulation by Heart Rate
and RyR2 Phosphorylation
Mean heart rate was 220618 bpm (Table S1, hearts 1–14 in
File S1) after 5 min perfusion with Krebs-Henseleit buffer. In six
experiments, where isoproterenol (1 mM) was added to the
perfusion buffer, heart rate increased by 7769% (n= 6) to
348623 bpm after 1 min (Table S1, hearts 9–14 in File S1).
Western blot analysis using anti-RyR2 and phospho antibodies
(Figure 1A) revealed a band corresponding with RyR2 at 560 kDa
(full length) and a fainter band corresponding to a 400 kDa, c-
terminal fragment similar to that seen in many previous studies
(e.g. [21,22]). We measured the effects of isoproterenol perfusion
on RyR2 phosphorylation to confirm that RyR2 had been
subjected to normal ß-adrenergic signalling processes in the heart.
ß-adrenergic stimulation of rat heart was correlated with an
increased phosphorylation at S2814 and S2808. The relative levels
of phosphorylation at S2814 after exposure to isoproterenol for
1 min increased 4-fold from that detected in control (p = 1025).
S2814 phosphorylation in control hearts was not different to RyR2
dephosphorylated by PP1 (Figure 1C, p= 0.16). RyRs from
control hearts showed a relatively high level of phosphorylation at
S2808. Western blots probed with pS2808 and DepS2808
indicated S2808 phosphorylation at 0.6960.07 and 0.8360.07
(respectively) of maximal PKA phosphorylation (Figure 1B).
Isoproterenol stimulation for 1 min increased S2808 phosphory-
lation to 0.8660.07 (p= 0.04) as determined by pS2808 staining.
However, we could not detect increased phosphorylation using
DepS2808. (Since our antibodies to S2030 showed no detectable
binding to RyR2 from rat heart, either control or isoproterenol
stimulated, S2030 was not examined.) The response of RyR2
phosphorylation to isoproterenol is typical of many previous
studies of ß-adrenergic stimulation (see discussion).
Effect of ß-adrenergic Stimulation on RyR2 Activity
We investigated the concentration dependencies of cytoplas-
mic and luminal Ca2+ and Mg2+ regulation of RyR2 at a bilayer
potential of 240 mV where the four identified Ca2+/Mg2+
regulation mechanisms in RyR2 are best revealed [23,24]. In
initial experiments, the cytoplasmic bath contained 100 nM
Ca2+ (diastolic [Ca2+]) with 2 mM ATP and the luminal bath
contained 0.1 mM Ca2+. Figure 2A (Traces 1 and 2) shows
representative single channel recordings from two experiments
on RyRs from control hearts performed under these conditions.
RyR2 from isoproterenol stimulated hearts showed similar
Figure 1. ß-adrenergic stimulation of heart phosphorylates
RyR2 at S2808 and S2814. Rat hearts were perfused with buffer
alone (control; examples from 2 hearts) or buffer containing 1 mM
isoproterenol for 1 min (Iso 1 min; examples from 2 hearts). SR
preparations, separated on tris-acetate 3–8% gel, were probed for
S2808 and S2814 phosphorylation. SR isolates from control hearts were
phosphorylated in vitro by endogenous CaMKII, exogenous PKA or
dephosphorylated by exogenous PP1 (Methods). Lanes within each
grouping were obtained from the same Western membranes and
displayed using identical image intensity and contrast. (A) Represen-
tative Western blots probed with pS2808, DepS2808 or pS2814
antibodies and re-probed with anti-RyR2. (B) Relative levels of S2808
phosphorylation and (C) S2814 phosphorylation. Band densities were
normalized to RyR2 loading in each lane relative to maximal band
densities of PP1 for DepS2808; PKA for pS2808 and CaMKII for pS2814.
Data show mean 6 sem of 3–6 hearts where number of replicates for
each heart are given in Table S1 in File S1 (* p,0.05, ** p,0.01).
doi:10.1371/journal.pone.0058334.g001
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gating kinetics, albeit with higher opening rates (Figure 2A,
Traces 3 and 4).
RyR2 was dephosphorylated to assess whether changes in RyR2
activity after ß-adrenergic stimulation were due to increased RyR2
phosphorylation. The activity of RyR2 from control and iso-
proterenol stimulated hearts was measured with 100 nM and
10 mM cytoplasmic [Ca2+]. RyR2 was dephosphorylated in-
bilayer by adding PP1 (7–10 units) to the cis bath for 5 min either
by local perfusion or by aliquot addition of PP1 [25]. Then the cis
chamber was perfused with solutions lacking PP1 and with
cytoplasmic [Ca2+] of 100 nM or 10 mM and the same channel
was recorded again (recordings shown in Figure 2B). In 8 of 8
experiments, PP1 reduced RyR2 opening rate at 100 nM
cytoplasmic Ca2+ (Figure 2C). Prior to PP1 incubation, RyRs
from isoproterenol treated hearts (n = 4) had significantly higher
opening rates than RyRs from control hearts (n = 4). However,
after PP1 incubation, there was no significant difference in
opening rate between the two groups. These results suggest that ß-
adrenergic stimulation increases RyR2 opening rate due to an
increased channel phosphorylation. PP1 inhibition of RyR2 from
control hearts suggests a significant phosphorylation-mediated
RyR2 stimulation in the absence of excess ß-adrenergic stimula-
tion. At 10 mM Ca2+ (n = 7), PP1 did not change either opening
rate or mean open duration (p = 0.86 or 0.13, respectively).
Figure 2. Effect of ß-adrenergic stimulation and RyR2 phosphorylation on RyR2 gating. (A) Representative single channel recordings of
RyR2 in the presence of cytoplasmic 2 mM ATP and with cytoplasmic [Ca2+] at the left of each trace. RyRs were from rat hearts perfused with control
buffer (Methods; Traces 1 & 2) or buffer containing 1 mM isoproterenol for 1 min (Traces 3 & 4). Each trace shows a separate experiment. At 240 mV
current is downward from the baseline (arrows). (B) Recordings of a RyR2 channel from a 1 min isoproterenol-exposed heart, before and after
incubation with cytoplasmic PP1 (7–10 units). Cytoplasmic [Ca2+] was 100 nM (Traces 1 & 2) and 10 mM (Traces 3 & 4). (C) Effect of PP1 on RyR2
opening rate at 100 nM Ca2+ compiled from 8 experiments like that shown in B (Traces 1 & 2). Four RyRs were used from the control and ISO groups.
(D) Opening rate, ko, mean open duration, To and open probability, Po, of RyR2 at 100 nM Ca
2+, for control RyR2 treated with PP1, RyR2 from control
and isoproterenol treated hearts. Mean values of ko, To and Po are normalised to their respective means in RyRs from control hearts. Asterisks indicate
significant differences from control (p,0.05).
doi:10.1371/journal.pone.0058334.g002
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Figure 2D shows the relative differences in RyR gating parameters
of three groups of RyRs; namely, 1) control RyRs that were
incubated with PP1 for 5 min, 2) RyRs from control hearts and 3)
RyRs from isoproterenol stimulated hearts. (Absolute values,
numbers of experiments and p-values are given in Table 1). ß-
Adrenergic stimulation of RyRs in control heart led to a 2.5-fold
increase in open probability (Po) due to an increase in RyR
opening rate whereas PP1 incubation led to a 15-fold decrease in
Po due to decreases in both opening rate and mean open duration.
Effect of ß-adrenergic Stimulation on Regulation of RyR2
by Ca2+
Cytoplasmic Ca2+ regulation. RyR2 from control and
isoproterenol stimulated hearts were strongly activated by
micromolar cytoplasmic Ca2+. Increasing cytoplasmic Ca2+ from
0.3 mM to 10 mM decreased RyR2 mean closed duration and
increased mean open duration (Figure 3A, Traces 1–4). Po
exhibited activation at mM Ca2+ (Figure 3B) and inhibition at
mM Ca2+ (below). Hill equations were fitted to the data (not
shown), using the Hill parameters in Table 2. Isoproterenol
stimulation for 1 min increased Po by 10-fold at low [Ca
2+] (Pmin)
with no significant effect on Ka for activation or maximal Ca
2+
activation (Pmax), suggesting that the Ca
2+ sensitivity of the
cytoplasmic Ca2+ activation site of RyR2 was not affected by
isoproterenol. The Ca2+ dependencies of Po were also reflected in
RyR2 opening rate (Figure 3C). At sub mM Ca2+, isoproterenol
stimulation caused a 10-fold increase in opening rate and this
difference became less as cytoplasmic Ca2+ increased. In these
experiments, there was no difference in the mean open duration
between the isoproterenol and control groups (p = 0.218,
Figure 3D) however in the luminal Ca2+ experiments, differences
were observed (see below).
Luminal Ca2+ regulation. Figure 4A shows RyR2 activation
by increasing luminal Ca2+ from 10 to 100 mM. Figures 4B–D
show the luminal [Ca2+]-dependencies of the Po, opening rate (ko)
and mean open time (To) of control and isoproterenol treated
RyR2 with diastolic (100 nM) cytoplasmic [Ca2+]. In the absence
of luminal Ca2+, RyR2 from control and stimulated groups had
a mean Po=0.003 and exhibited a bell-shaped luminal [Ca
2+]-
dependence with peak activity occurring in the presence of
,100 mM. Peak Po of RyRs from the isoproterenol-stimulated
hearts was 4-fold larger (Po=0.045) than control (Figure 4B, curves
show fits of Hill equations using Hill parameters in Table 2). The
only Hill parameter that showed a significant difference between
RyRs from control and stimulated hearts was Pmax. Therefore,
isoproterenol-stimulation enhances the sensitivity of RyR2 to
changes in luminal Ca2+ concentration without altering the Ka for
activation or the Ki for inhibition. This enhanced sensitivity was
also reflected by increases in both RyR2 opening rate and mean
open duration (Figures 4C & D, curves show fits of RyR2 gating
model using parameters in Table S3 in in File S1). Since
measurements of opening rate are carried out on closed channels
(opening rate = 1/mean closed duration), the increase in the
luminal Ca2+-dependence of opening rate unambiguously indi-
cates an increased effect of Ca2+ binding to the luminal Ca2+
activation site of RyR2 [26,27].
Effect of ß-adrenergic Stimulation on Mg2+ inhibition via
the Luminal and Cytoplasmic Ca2+ Activation Sites
Cytoplasmic and luminal Mg2+ inhibition of RyR2 at diastolic
cytoplasmic [Ca2+] (,1 mM) was previously shown to be due to
Mg2+ competing with Ca2+ at cytoplasmic and luminal Ca2+
activation sites; (at higher cytoplasmic [Ca2+] cytoplasmic Mg2+
inhibits RyR2 by mimicking Ca2+ at the low affinity inhibition site
[24] and this is dealt in the following section). Mg2+ inhibition via
the cytoplasmic and luminal Ca2+ activation sites was investigated
here by measuring Mg2+ inhibition in the presence of 100 nM
cytoplasmic Ca2+ (Figures 5 and 6). Cytoplasmic and luminal
Mg2+ inhibition of Po were fitted with Hill equations (not shown;
Hill parameters in Table 3). RyR2 gating model is compared with
the data in Figures 5, 6, and 7 (parameters in Table S3 in File S1,
note that model fits did not minimise least squares differences to
data in Figure 5 because fits were optimised for all data in
Figures 5, 6, and 7 using the same parameters). Cytoplasmic Mg2+
inhibition was no different (p = 0.56) in RyRs from control and
stimulated hearts (Figure 5A). However, adrenergic stimulation
reduced the effects of luminal Mg2+ inhibition of Po (Figure 6A),
increasing the Ki (p = 0.003) by 4.5-fold compared with control
(Table 3). The decreased luminal Mg2+ inhibition seen after
adrenergic stimulation was reflected in increased mean open
durations (Figure 6D) and a decreased effect of Mg2+ on the
opening rate (Figure 6C). For reasons outlined in the previous
paragraph, the alleviation of Mg2+ effect on the opening rate
indicates a modulation of a luminal facing site on the RyR.
Effect of ß-adrenergic Stimulation on Mg2+ Inhibition via
the Cytoplasmic Ca2+/Mg2+ Inhibition Site
Cytoplasmic Ca2+ and Mg2+ can inhibit RyR2 by binding to
a low affinity divalent binding site [28]. This site underlies Ca2+
inhibition and Mg2+ inhibition at mM concentrations, seen when
cytoplasmic [Ca2+] exceeds 10 mM. Figure 7A shows Ca2+
inhibition of RyRs from control and stimulated hearts. Hill
equations were fitted to the data, using Hill parameters in Table 2.
Isoproterenol alleviated Ca2+ inhibition of RyRs by increasing Ki
from 1.5 to 2.5 mM, indicating decreased Ca2+ inhibition via the
low affinity divalent binding site.
We also investigated effects of adrenergic stimulation on Mg2+
inhibition via the Ca2+ inhibition site by measuring Mg2+
inhibition of Po in the presence of 10 mM cytoplasmic Ca2+
(Figure 7B). We found that RyR2 from stimulated hearts showed
Table 1. Comparison of opening rates (1/mean closed duration), mean open durations and open probability for RyR2 from various
treatment groups in Figure 2D: RyRs from control hearts incubated with PP1 for 5 min, control and stimulated with isoproterenol
for 1 min.
treatment opening rate s21 mean open duration ms open probability61023 n
PP1 0.5260.21 0.02* 2.860.5 0.04* 0.960.4 0.0001* 11
Control 2.060.5 7.960.9 1364 39
ISO 1 min 4.160.8 0.007* 9.861.2 0.3 3266 0.004* 95
Data show mean 6 sem and p values for deviation from control hearts. Asterisks indicate significant difference (p,0.05). n indicates the number of experiments.
doi:10.1371/journal.pone.0058334.t001
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less Mg2+ inhibition (at 1 mM Mg2+) than control, indicating
decreased Mg2+ inhibition via the low affinity divalent binding site.
Finally, we measured the Ca2+ activation properties of rat
RyR2s in the presence of physiological concentrations of
cytoplasmic Mg2+ (1 mM) and in the presence of 1 mM luminal
Ca2+ (Figure 7C). Under these conditions, the Ka for cytoplasmic
Ca2+ was 80 and 65 mM for RyRs from control and stimulated
hearts, respectively. Although RyR2 from stimulated hearts
showed higher mean Po than those from control hearts over the
range pCa 4–5, none of the differences reached significance in
these experiments.
RyR Gating Model
Our observations are considered in the framework of a kinetic
model originally developed for gating for sheep RyR2 that
incorporates luminal and cytoplasmic regulation [24,27]. We
adapted the model to the rat RyR and use it to gain insight into
the mechanisms of ß-adrenergic regulation of rat RyR2 by
intracellular Ca2+ and Mg2+ and to predict the effect of these
mechanisms on RyR activity in the cell.
The RyR2 gating model considers Ca2+/Mg2+ regulation of
RyR2 in terms of four Ca2+ sensing sites (L-, A-, I1- and I2-
sites, see Figure 8A). The experimental evidence for each of
these sites is reviewed elsewhere [26,27]. Two Ca2+-activation
sites in the luminal (L-site) and cytoplasmic domains (A-site) of
RyR2 have Ca2+ affinities of 8 mM and 2 mM, respectively.
These sites trigger a common gating mechanism to produce
synergistic activation by luminal and cytoplasmic Ca2+. The
cytoplasmic domain also possesses two inhibitory sites with Ca2+
affinities of 0.4 mM (I1-site) and 1.5 mM (I2-site). Magnesium,
which competes with Ca2+ at the L-, A- and I2-sites, inhibits
RyRs and shapes the Ca2+-dependent activation of RyRs [24].
Luminal Ca2+ and Mg2+ can pass through open channels and
act at cytoplasmic facing sites.
RyR opening rates and mean open durations (Figures 3, 4, 5,
and 6) were fitted by the model (solid and dashed lines; fit
parameters in Tables S2 and S3 in File S1). The model
accounted for most of the key features of the data with the
exception of the high RyR opening rate observed in the
presence of 100 mM cytoplasmic Ca2+ (Figure 3C). None the
less, the model did provide good predictions of Po and To under
this condition. Changes in RyR2 activity with adrenergic
stimulation were reflected in changes in four parameters
associated with three RyR2 sites, namely: 1) The opening rate
in response to Ca2+ binding to the luminal Ca2+ activation site
(L-site) increased 20-fold, accounting for the increased opening
rate at low cytoplasmic [Ca2+] (Figure 3C) and increased
luminal Ca2+ activation of opening rate (Figure 4C). 2) There
was a 4-fold decrease in the Mg2+ affinity of the L-site,
accounting for the decrease in luminal Mg2+ inhibition
(Figure 6C), 3) RyR2 closing via the high affinity Ca2+
inactivation site (I2-site) was slowed 2-6-fold, accounting for
the increase in mean open duration (Figure 4D). 4) The affinity
of the cytoplasmic Ca2+/Mg2+ inhibition site (I1-site) was
reduced by 40%, accounting for the reduced Ca2+ inhibition
(Figure 7A) and Mg2+ inhibition in the presence of 10 mM
cytoplasmic Ca2+ (Figure 7B). Interestingly, we found no effect
of adrenergic stimulation on the cytoplasmic Ca2+ activation site
(A-site). Model fits to the data indicated a 25% change in the
Mg2+ affinity of the A-site which accounted for the systematic,
though non-significant increase in RyR activity in Figure 7C.
We then predicted how the activity of RyRs might respond
to ß-adrenergic stimulation within the cell using assumptions for
the cell interior that have been reviewed and justified elsewhere
[24]. Briefly, we assumed that 1) the free Mg2+ in cytoplasm
and lumen is 1 mM, 2) Ca2+ and Mg2+ fluxes through RyR2
are slightly larger in the presence of intracellular [K+] than with
250 mM Cs+ and that 3) intracellular Ca2+ buffering is
substantially weaker and slower in the cell than in our bilayer
solutions. Assumptions 2 and 3 affect the feed-through
parameters, XA and XI in the model (see Table S3 in File S1).
The model predicts that under systolic conditions where
cytoplasmic [Ca2+] exceed 1 mM, ß-adrenergic stimulation causes
a 3-fold increase in RyR2 Po (Figure 8B). This is similar to a 2-fold
stimulation of Po measured at systolic levels of Ca
2+ and Mg2+
(Figure 7C). Under diastolic conditions (cytoplasmic [Ca2+]
,100 nM), the model predicts a RyR2 open probability in the
range 1027 to 1026 which is far too small to be measured by single
channel recording. Under these conditions, ß-adrenergic stimula-
tion increases RyR2 Po by 20-fold, which was due to an increase in
the ability of luminal Ca2+ to activate the RyR (Figure 8C).
We explored how the modulation of the L-, I1- and I2-sites
during ß-adrenergic stimulation contribute to increasing RyR2 Po
under both diastolic (Figure 8D) and systolic conditions (Figure 8E).
In diastole, the model predicted that the increased action of Ca2+
binding to the L-site contributes a 3-fold increase in RyR2 activity
during ß-adrenergic stimulation (Figure 8D, L-site (Ca2+)), de-
creased Mg2+ inhibition at the L-site contributed another 50%
increase (Figure 8D, L-site (Ca2++Mg2+)) and reduced cytoplasmic
Mg2+ inhibition contributed another 3-fold increase in activity
Table 2. Parameter values for the Hill equation from least-squares fits to cytoplasmic and luminal Ca2+ regulation of Po in Figures 3,
4 and 7A.
treatment Pmax Pmin610
23 Ka, mM Ha n Ki, mM Hi n
cytoplasmic Ca2+
Control 0.860.12 3.560.6 2.260.3 261 15 1.560.1 360.4 6
ISO (1 min) 0.860.11 3864* 3.361.2 261 20 2.560.1* 360.4 5
luminal Ca2+
Control 0.01360.003 – 1067 2{ 16 0.7660.5 1{ 16
ISO (1 min) 0.06460.01* – 27615 1{ 33 0.5160.2 1{ 3
The Hill equation for inhibition by Ca2+ is: P0~Pmax
.
1z X 2z

Ki
 Hi . The corresponding equation for activation is:
P0~ Pmax{Pminð Þ ½X 2z

Ka
 .
1z X 2z

Ka
 Ha 
zPmin .
*indicates significant difference from control value, p,0.05.
{indicates where H was not adjusted during fitting. n indicates the number of experiments.
doi:10.1371/journal.pone.0058334.t002
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(Figure 8D, full; I1-site and A-site contributed ,1.7-fold each).
The I2- and A-sites made no significant contribution to ß-
adrenergic stimulation. In systole, the only significant contribution
to ß-adrenergic stimulation came from a decrease in cytoplasmic
Mg2+ inhibition (Figure 8E).
Discussion
Effect of ß-adrenergic Stimulation on RyR2 Regulation by
Ca2+ and Mg2+
Here, we report the first characterization of steady-state changes
in RyR2 regulation by cytoplasmic and luminal Ca2+ and Mg2+ in
response to acute ß-adrenergic stimulation of the heart by
isoproterenol. We find that ß-adrenergic stimulation is associated
with a marked change in RyR2 regulation by intracellular Ca2+
and Mg2+ and an increase in the level of phosphorylation of S2808
and S2814 on the RyR. ß-adrenergic-induced changes in RyR
function were reversed when RyR2 was dephosphorylated by
incubation with PP1, indicating that ß-adrenergic-induced
changes were mediated by phosphorylation.
Our findings are consistent with, and substantially extend
previous observations that RyR2 from ß-adrenergic stimulated
mouse hearts that had a higher opening rate than unstimulated
hearts [2,6,29] at diastolic cytoplasmic Ca2+ (150 nM) and supra-
physiological luminal Ca2+ (50 mM). However, the degree of RyR
activation seems to depend on the presence of ATP and Mg2+. In
the absence of ATP and Mg2+, isoproterenol stimulation caused
a 15-fold increase in RyR2 activity and less than a 2-fold increase
Figure 3. Activation of RyR2 by cytoplasmic Ca2+. (A) Single channel recordings of RyR2 from control rat hearts in the presence of cytoplasmic
2 mM ATP and with cytoplasmic [Ca2+] at the left of each trace. Channel openings are downward from the baseline (arrows). (B) Cytoplasmic Ca2+-
dependence of open probability (Po) of RyR2 from control (N, n = 4–16) and stimulated (isoproterenol for 1 min; #, n = 5–20) hearts. Asterisks
indicate p,0.05 for differences between # and N. Solid and dashed curves show least-squares Hill fits to the control and isoproterenol data. (C)
Cytoplasmic Ca2+-dependency of RyR2 opening rate (ko) from control (N, n = 4–16) and isoproterenol-stimulated (# n= 4–20) hearts. (D) Same as C
but now plotting RyR2 mean open duration (To). Solid and dashed curves show RyR2 gating model fits to control and isoproterenol data.
doi:10.1371/journal.pone.0058334.g003
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in the presence of ATP [6]. Another study [29] reported that
exercise caused a 5-fold increase in RyR activity in the presence of
Mg2+. Here, we present the first investigation of how ß-adrenergic
stimulation alters the various Ca2+ and Mg2+ regulation mechan-
isms in RyR2 and their relative roles in physiological Ca2+ release
from the SR. We identify four actions of ß-adrenergic stimulation
on RyR2 gating which we associate with three mechanisms: #1)
a 3- to 5-fold increase in RyR2 activation by luminal Ca2+
(Figure 4) and decreased RyR2 inhibition by luminal Mg2+
(Figure 6); both actions being attributable to changes in the
luminal Ca2+ binding site (L-site) [24]. #2) diminished Mg2+
inhibition at mM concentrations (Figure 7) attributable to
decreased affinity of the I1-site and possibly the A-site, and #3)
increased RyR2 mean open durations (Figure 4D), attributable to
a decreased rate of cytoplasmic Ca2+ inactivation (I2-site). The
cytoplasmic Ca2+ activation, associated with the cytoplasmic Ca2+
activation site (A-site; [28]) was not altered by ß-adrenergic
stimulation. This novel data show that changes in luminal Ca2+
activation make the dominant contribution to increases in Po
observed at low cytoplasmic [Ca2+] whereas at higher [Ca2+], the
dominant contribution comes from alleviation of cytoplasmic
Mg2+ inhibition.
Figure 4. Activation of RyR2 by luminal Ca2+. (A) Single channel recordings of RyR2 from control (Traces 1 & 2) and isoproterenol stimulated
hearts (1 min, Traces 3 & 4) in the presence of cytoplasmic 2 mM ATP and with luminal [Ca2+] at the left of each trace. (B) Luminal Ca2+-dependencies
of open probability (Po) of RyR2 from control (N, n = 4–16) and isoproterenol-stimulated (#, n = 4–33) hearts. (C) Luminal Ca2+-dependencies of RyR2
opening rate (ko) from control (N n=4–16) and isoproterenol-stimulated (#, n = 4–16) hearts. (D) Same as C but now plotting RyR2 mean open
duration (To). Solid and dashed curves in B show least-squares Hill fits to the control and isoproterenol data. Solid and dashed curves in C & D show
fits of the RyR2 gating model to data.
doi:10.1371/journal.pone.0058334.g004
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By fitting the data obtained here from rat RyR2 with a model
previously used to account for Ca2+ and Mg2+ regulation of sheep
RyR2 [24] and extrapolating this model to physiological ionic and
Ca2+ buffering conditions, we predict that different combinations
of these mechanisms underlie stimulation of RyR2 activity in
diastole and systole. In diastole, ß-adrenergic stimulation causes
a 20-fold increase in RyR Po, mainly due to mechanisms #1 and
#2 whereas in systole, it causes a smaller, 3-fold increase in Po,
mediated by mechanism #2.
Phosphorylation of RyRs during ß-adrenergic Stimulation
Western Blot analysis shows that ß-adrenergic stimulation of
intact hearts induces a 4-fold increase in S2814 phosphorylation,
which is at the high end of the range reported by previous studies
of perfused hearts [30,31]. In addition, S2814 phosphorylation
occurs within 60 s of ß-adrenergic stimulation suggesting a role in
the acute changes in cardiac function induced by isoproterenol.
Several studies show that S2814 phosphorylation occurs as a result
Table 3. Parameter values for the Hill equation derived from
least-squares fits to Mg2+ inhibition of Po shown in Figures 5
and 6.
treatment Pmax Ki, mM Hi n
cytoplasmic Mg2+ (100 nM Ca2+)
Control 0.01960.015 1366 0.960.7 10
ISO (1 min) 0.1060.04 26611 0.860.5 14
luminal Mg2+ (0.1 mM Ca2+)
Control 0.02360.011 78614 1.360.5 7
ISO (1 min) 0.03260.022 3606100* 1.361.0 12
Hill equation for inhibition by Mg2+ is:Po~Pmax
.
1z X 2z

Ki
 Hi .
*indicates significant difference from control value, p,0.05.
doi:10.1371/journal.pone.0058334.t003
Figure 5. Inhibition of RyR2 by cytoplasmic Mg2+. (A) Single channel recordings of RyR2 from control (Traces 1 & 2) and isoproterenol
stimulated hearts (1 min, Traces 3 & 4) in the presence of cytoplasmic 2 mM ATP and with cytoplasmic [Mg2+] at the left of each trace. (B-D) Effects
on gating kinetics of inhibition by cytoplasmic Mg2+ of RyR2 from control (N n= 2–10) and from 1 min isoproterenol stimulated hearts (# n=5–13).
(B) Open probability, Po, and (C) opening rate, ko, relative to that in the absence of Mg
2+. (D) [Mg2+]-dependencies of mean open duration, To. Solid
and dashed curves show fits of the RyR2 gating model to the control and isoproterenol data, respectively.
doi:10.1371/journal.pone.0058334.g005
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of the raised cytoplasmic [Ca2+] resulting from increased heart
rate during adrenergic stimulation which activates CaMKII
[2,32].
Western blots with pS2808 antibody indicated that S2808 was
substantially phosphorylated before ß-adrenergic stimulation and
that ß-adrenergic stimulation increased phosphorylation at this site
(Figure 1). We used the DepS2808 antibody that detected
dephosphorylated S2808 as a cross check for the pS2808
experiments. The experiments using DepS2808 confirmed the
high basal levels of S2808 phosphorylation but not the effects of ß-
adrenergic stimulation due to the low levels of antibody staining in
these experiments. Our pS2808 data confirm antibody measure-
ments of basal and ß-adrenergic-induced phosphorylation levels of
S2808 in rat perfused hearts [30], quiescent cardiomyocytes
[33,34] and other species [19,21,31,34,35]. However, studies using
32P incorporation assays report larger relative increases in S2808
phosphorylation that imply lower basal phosphorylation levels
than we report. Exercise in mice [29] and isoproterenol
administered to rats [6] induced 3-fold increases in PKA
phosphorylation in RyR2.
We did not examine phosphorylation at S2030 because we
could not detect pS2030 antibody binding to RyR2. Previous
characterization of several antibodies by other workers also failed
to reliably measure S2030 phosphorylation [33]. However, ß-
adrenergic-induced changes in phosphorylation at S2030 were
detected by others in mouse and rat using antibodies not available
to us [31,34]. Potential changes in phosphorylation at S2030
would not affect our main conclusions regarding how RyR2 gating
changes in response to ß-adrenergic stimulation.
Synergistic Activation of RyR by Phosphorylation at
Multiple Sites
A picture is emerging where phosphorylation at any of the three
known phosphorylation sites on the RyR2 increases its activation
by luminal Ca2+. The ß-adrenergic-induced increase in luminal
Ca2+ activation, that correlated in this study with increased
phosphorylation of S2814 and S2808, is similar to that reported by
constitutive phosphorylation of S2030 in recombinant S2030D
mice [9,14] and PKA-induced phosphorylation of S2808 [36]. ß-
adrenergic stimulation of the heart is substantially reduced in
Figure 6. Inhibition of RyR2 by luminal Mg2+. (A) Single channel recordings of RyR2 from control (Traces 1 & 2) and isoproterenol stimulated
hearts (1 min, Traces 3 & 4) in the presence of cytoplasmic 2 mM ATP and with luminal [Mg2+] at the left of each trace. (B–D) Effects on gating
kinetics of inhibition by luminal Mg2+ of RyR2 from control (& n= 3–7) and from 1 min isoproterenol stimulated hearts (% n= 3–7). (B) Open
probability, Po, and (C) opening rate, ko, relative to that in the absence of Mg
2+. (D) [Mg2+]-dependencies of mean open duration, To. Solid and dashed
curves in B show least-squares, Hill fits to the control and isoproterenol data. Solid and dashed curves show fits of the RyR2 gating model to the
control and isoproterenol data, respectively.
doi:10.1371/journal.pone.0058334.g006
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S2808A (dephosphorylated) transgenic mice [36,37]. These
apparently conflicting findings could be reconciled if multiple
phosphorylation sites have a synergistic effect on RyR2 activity
and that adrenergic stimulation requires phosphorylation at both
S2814 and S2808. This would not be surprising given the close
proximity of S2808 and S2814 in the RyR2 sequence.
RyR Activity during ß-adrenergic Stimulation Compared
with Manipulation of Phosphorylation by Exogenous
Enzymes
Regulation of RyR2 by phosphorylation and luminal Ca2+
and Mg2+ is controversial. Our finding that the effect of ß-
adrenergic stimulation strongly correlates with CaMKII phos-
phorylation at S2814 and that its effect on RyR2 activity
depends on the ionic conditions used in bilayer experiments
appears to reconcile some conflicting reports using exogenous
CamKII to phosphorylate RyRs. For example, the ß-adrenergic-
induced increase in RyR2 luminal Ca2+ activation in the
presence of 100 nM cytoplasmic Ca2+ was found in other
studies of S2814 phosphorylation by CaMKII [38] and the
phospho-mimetic S2814D mutation [2]. The contradictory
findings that CaMKII had either no effect on RyR2 activity
[38], or caused a decrease in activity [39] were obtained using
cytoplasmic Ca2+ in excess of 1 mM. Under such conditions we
also find that ß-adrenergic stimulation also had no effect on
RyR2 activity. We could not detect an effect of adrenergic
stimulation on RyR2 inhibition by cytoplasmic Mg2+ in the
presence of 100 nM cytoplasmic Ca2+; a phenomenon associ-
ated with the A-site [28]. However, ß-adrenergic stimulation did
reduce Mg2+ inhibition at high cytoplasmic Ca2+ (associated
with the I1-site); consistent with the finding that exogenous
CaMKII removes Mg2+ inhibition with 5–10 mM Ca2+ [8,25].
Hain et al. [25] found that activation of endogenous CaMKII
caused inhibition of RyRs that were previously dephosphory-
lated by PP1. In our study, ß-adrenergic activation of RyR2
associated with CamKII activity could be because RyR2 in our
experiments were not dephosphorylated prior to stimulation.
Technical Limitations
The aim of this study was to identify the effects of acute ß-
adrenergic stimulation on RyR2 function that occur in a time-
frame that similar to the rate of onset of ß-adrenergic
stimulation in the heart. To achieve this it was necessary adopt
the in vitro Langendorff perfusion method so that hearts could
be snap frozen within one minute of administering isoproter-
enol. (Flash freezing methods have been found to accurately
capture the phosphorylation state of RyR2 [6]). Sustained
perfusion (15 min) of isolated hearts appears to reduce
phosphorylation levels of RyR2 compared to hearts in situ (c.f.
Fig 1A,C in [6]). Therefore, control hearts in our study were
perfused for just long enough for heart rate to reach a steady
level (5 min). This approach would minimise run-down in RyR2
phosphorylation during perfusion but at the cost of ensuring
that hearts have fully recovered from explantation.
We find that the binding of antibodies for S2808 and S2814
to RyRs that were incubated with PKA and CamKII
phosphorylation indicated that S2808 was mainly phosphorylat-
ed by PKA and S2814 by CamKII. In addition, these kinases
appeared to phosphorylate the alternate sites to 20–50%,
confirming previous antibody experiments [19] indicating that
PKA and CamKII act on both sites. However, given that 32P
incorporation experiments find that PKA and CamKII are each
highly specific for S2808 and S2814, respectively [40], we can’t
rule out the possibility that our antibodies are cross-reacting
with both phosphorylated serines.
In conclusion, ß-adrenergic stimulation induces changes in at
least three Ca2+ and Mg2+ regulation mechanisms in RyR2. In
bilayer experiments, these changes produce changes in channel
activity that depended on the experimental conditions, which
can account for conflicting reports of phosphorylation-induced
Figure 7. Regulation of RyR2 open probability by cytoplasmic
Ca2+ and Mg2+. RyRs from control (N, n = 3–8) and 1 min iso-
proterenol stimulated hearts (#, n = 3–9). All recording solutions
contained 2 mM ATP. (A) Dependence of open probability on
cytoplasmic [Ca2+]. (B) Dependence of normalised open probability
on cytoplasmic [Mg2+] in the presence of 10 mM cytoplasmic Ca2+. (C)
Cytoplasmic Ca2+ activation of Po in the presence of 1 mM cytoplasmic
Mg2+ and 1 mM luminal Ca2+. Asterisks indicates significant differences
between N and # (p,0.05). Solid and dashed curves show fits of the
RyR2 gating model to the control and isoproterenol data, respectively.
doi:10.1371/journal.pone.0058334.g007
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Figure 8. Model simulations of RyR2 open probability in ß-adrenergic stimulated and non-stimulated cells. (A) Ca2+/Mg2+ regulatory
sites on the cardiac RyR. The hypothetical locations of four divalent cation sites known to regulate the gating activity of RyR2 are shown on
a structural silhouette obtained from Samso et al. [41]. The names given to these sites are indicated on the left and the corresponding Ca2+- Mg2+
affinities of the sites in Rat RyR2 are shown on the right (The Mg2+ affinity of the I2-site is unknown). The arrows indicate the ability of Ca
2+ on the
luminal and cytoplasmic sides of the membrane to access Ca2+ sites on the cytoplasmic domains of the channel [42]. (B) Cytoplasmic [Ca2+]
dependencies of Po with 1 mM luminal Ca
2+ and (C) luminal [Ca2+] dependencies of Po with 100 nM cytoplasmic Ca
2+. Simulation of RyR2 from
control (solid lines) and 1 min isoproterenol stimulated hearts (dashed lines). (D-E) Contributions of each site to ß-adrenergic stimulation of RyR Po in
diastole (pCa 7; D) and systole (pCa 5; E). The categories show the cumulative effects of four adrenergic modulation mechanisms; namely: increasing
Ca2+ activation due to the luminal L-site (L-site (Ca2+)), alleviating Mg2+ inhibition at the L-site site (L-site (Ca2++Mg2+)), decreasing inactivation by the
I2-site (I2-site) and decreasing cytoplasmic Mg
2+ inhibition by the I1- and A-sites (full). The left and right categories on each bar chart show Po for
control and adrenergic stimulated RyRs (control and full, respectively). The relative contributions of these sites to adrenergic stimulation are different
at diastolic and systolic concentrations of cytoplasmic Ca2+.
doi:10.1371/journal.pone.0058334.g008
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changes in RyR2 function. In the cell, our RyR2 gating model
predicts that ß-adrenergic stimulation of RyR2 is 20-fold in
diastole but only 3-fold in systole; reflecting the different
mechanisms underlying stimulation in each case.
Supporting Information
File S1 Supplementary material detailing the methods
and the model for Ca2+/Mg2+ dependent gating of RyR2.
The file gives additional information for methods of 1) perfusion of
isolated rat hearts, 2) data acquisition and analysis, 3) SDS PAGE
and Western Blotting, 4) in-vitro Exogenous PP1, PKA and
endogenous CaMKII activity assays and 5) a summary of heart
rates and phosphorylation levels determined by Western Blots for
each heart used in this study (Table S1). Additional details of the
model are included in Tables S2 and S3.
(DOCX)
File S2 Figures of supporting information on the
analysis of phosphorylation of RyR2 in Western Blots.
These figures demonstrate 1) the feasibility of reprobing Western
Blots, 2) the time course of PP1 incubation of SR vesicles, 3) the
time course of binding by antibodies to phospho-S2808 and
phospho-S2814 in response to PKA and CamKII incubation, 4)
that endogenous phosphatases do not alter S2808 phosphorylation
in bilayer experiments and 5) that ATP does not alter S2814
phosphorylation in bilayer experiments.
(PDF)
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